Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-12-30 4:11 pm Sale | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 4,631,432 4.6% | -2,000,000 (-30.16%) | View |
| 2022-09-02 10:18 am Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Soleus Capital Master Fund L.P. | 4,982,789 5% | 4,982,789 (New Position) | View |
| 2022-07-08 4:57 pm Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BlackRock Inc. BLK | 3,323,843 3.4% | -4,022,979 (-54.76%) | View |
| 2022-05-10 12:40 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 5,175,500 5.2% | 5,175,500 (New Position) | View |
| 2022-04-11 09:01 am Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | FMR LLC | 10,873,853 11.011% | 9,301,567 (+591.60%) | View |
| 2022-02-14 08:48 am Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | RTW INVESTMENTS LP | 7,554,817 7.7% | 327,453 (+4.53%) | View |
| 2022-02-11 4:10 pm Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | ORBIMED ADVISORS LLC | 0 0% | -4,845,247 (Position Closed) | View |
| 2022-02-11 4:07 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | REGENERON PHARMACEUTICALS INC. REGN | 1,809,098 1.84% | 1,809,098 (New Position) | View |
| 2022-02-11 10:01 am Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Avoro Capital Advisors LLC | 6,950,000 7.1% | -1,050,000 (-13.13%) | View |
| 2022-02-03 4:41 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BlackRock Inc. BLK | 7,346,822 7.5% | 304,054 (+4.32%) | View |
| 2021-10-12 12:34 pm Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | STATE STREET CORP STT | 2,047,619 2.09% | -8,163,237 (-79.95%) | View |
| 2021-09-10 2:27 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | STATE STREET CORP STT | 10,210,856 10.41% | 10,210,856 (New Position) | View |
| 2021-08-16 4:32 pm Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | RA CAPITAL MANAGEMENT L.P. | 0 0% | -9,502,383 (Position Closed) | View |
| 2021-04-16 3:11 pm Unchanged | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 6,631,432 6.8% | 0 (Unchanged) | View |
| 2021-04-09 4:54 pm Purchase | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 6,631,432 6.8% | 500,000 (+8.15%) | View |
| 2021-03-18 2:21 pm Purchase | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 6,131,432 6.3% | 915,281 (+17.55%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | RA CAPITAL MANAGEMENT L.P. | 9,502,383 9.7% | 9,502,383 (New Position) | View |
| 2021-02-16 3:46 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 5,216,151 5.4% | 968,870 (+22.81%) | View |
| 2021-02-12 4:37 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | ORBIMED ADVISORS LLC | 4,845,247 4.97% | 901,157 (+22.85%) | View |
| 2021-02-12 09:17 am Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | RTW INVESTMENTS LP | 7,227,364 7.42% | 840,757 (+13.16%) | View |